SA
NBIX logo
Neurocrine Biosciences, Inc.(NBIX)
Closing price · checked 8:45 PM ETAbout this dataData status
$162.78▼-3.06 (-1.84%)
Pre-Market:$162.00-0.78 (-0.48%)· 8:45 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 22.1)

Overview →

Neurocrine Biosciences, Inc. (NBIX)

R&D to Revenue

35.51%

Fiscal year · Period ending:

NBIX logo

NBIX R&D to Revenue

Latest reported35.51%
NBIX FY R&D/Revenue (65.63% → 35.51%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

NBIX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Neurocrine Biosciences, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
35.5078%
31.0406%
29.9401%
31.1547%
28.9457%
26.2931%
25.3775%
34.5301%
56.8145%
628.6067%
412.2161%
0%
1,344.5701%
69.9341%
39.9817%
92.9853%
1,141.9573%
1,397.3333%
6,698.1209%
248.9626%
86.0674%
135.092%
127.4616%
603.7074%
180.0761%
275.754%
173.8095%
136.25%
76.2452%
65.625%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.